LifeWave Hi-Tech Medical Devices Ltd. (TASE:LIFE) is expanding its collaboration with the German Army in a efficacy study of the company's BST (bioelectrical signal therapy) device for the treatment of knee trauma and the healing of broken bones.
The study will begin when LifeWave delivers the BST devices to Germany over the next few weeks.
In late June, LifeWave announced its first insurance indemnification agreement for treatment with the BST device in Germany. The deal came after the company intensified its marketing activity in the country in collaboration with local firm, Mex, which specializes in selling new medical technologies in the country.
LifeWave's share price fell 2.1% today to NIS 2.96, giving a market cap of NIS 49 million.
Published by Globes [online], Israel business news - www.globes-online.com - on November 18, 2010
© Copyright of Globes Publisher Itonut (1983) Ltd. 2010